Supplemental material
Open access
2,158
Views
1
CrossRef citations to date
0
Altmetric
Report
Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer
Gareth C. G. DaviesUCB Pharma, Slough, UKhttps://orcid.org/0000-0001-5180-3143View further author information
, Neesha DediUCB Pharma, Slough, UKView further author information
, Paul S. JonesUCB Pharma, Slough, UKView further author information
, Lara KevorkianUCB Pharma, Slough, UKView further author information
, David McMillanUCB Pharma, Slough, UKhttps://orcid.org/0000-0001-9376-0284View further author information
, Cristina OttoneUCB Pharma, Slough, UKView further author information
, Monika-Sarah E. D. SchulzeUCB Pharma, Slough, UKhttps://orcid.org/0000-0002-3799-0808View further author information
, Anthony Scott-TuckerUCB Pharma, Slough, UKView further author information
, Roohi TewariUCB Pharma, Slough, UKView further author information
, Shauna WestUCB Pharma, Slough, UKView further author information
, Michael WrightUCB Pharma, Slough, UKView further author information
& Tania F. RowleyUCB Pharma, Slough, UKCorrespondence[email protected]
https://orcid.org/0000-0001-6242-0527View further author information
show allhttps://orcid.org/0000-0001-6242-0527View further author information
Article: 2289681
|
Received 21 Apr 2023, Accepted 27 Nov 2023, Published online: 12 Dec 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.